China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Net Asset Quality Index

Latest as of September 2025: 71.5%

China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Net Asset Quality Index of 71.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥17.01 Billion minus total liabilities of CN¥4.85 Billion yields net assets of CN¥12.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 600062 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Quality Index

71.5%
Equity / Total Assets

Net Assets

CN¥12.16 Billion
CNY

Total Assets

CN¥17.01 Billion
CNY

Total Liabilities

CN¥4.85 Billion
CNY

China Resources Double-Crane Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1994–2024)

This chart shows how China Resources Double-Crane Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 31 annual periods from 1994 to 2024. As of September 2025, the index stands at 71.5%, representing net assets of CN¥12.16 Billion against total assets of CN¥17.01 Billion CNY. See 600062 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for China Resources Double-Crane Pharmaceutical Co Ltd (1994–2024)

The table below presents the year-by-year Net Asset Quality Index for China Resources Double-Crane Pharmaceutical Co Ltd from 1994 to 2024, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 600062 company net worth.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 66.6% CN¥11.11 Billion CN¥16.69 Billion CN¥5.57 Billion ▼ -9.8 pp
2023 76.4% CN¥11.79 Billion CN¥15.43 Billion CN¥3.64 Billion ▲ +2.3 pp
2022 74.1% CN¥10.73 Billion CN¥14.48 Billion CN¥3.75 Billion ▼ -2.5 pp
2021 76.6% CN¥10.48 Billion CN¥13.68 Billion CN¥3.20 Billion ▲ +1.1 pp
2020 75.5% CN¥9.38 Billion CN¥12.42 Billion CN¥3.04 Billion ▼ -1.4 pp
2019 76.9% CN¥8.68 Billion CN¥11.28 Billion CN¥2.60 Billion ▲ +0.2 pp
2018 76.7% CN¥7.91 Billion CN¥10.31 Billion CN¥2.40 Billion ▼ -6.4 pp
2017 83.2% CN¥7.85 Billion CN¥9.44 Billion CN¥1.59 Billion ▼ -2.2 pp
2016 85.4% CN¥7.04 Billion CN¥8.24 Billion CN¥1.20 Billion ▲ +2.5 pp
2015 82.9% CN¥6.43 Billion CN¥7.76 Billion CN¥1.33 Billion ▼ -3.0 pp
2014 85.9% CN¥5.68 Billion CN¥6.62 Billion CN¥934.93 Million ▲ +3.5 pp
2013 82.3% CN¥5.34 Billion CN¥6.48 Billion CN¥1.14 Billion ▲ +10.0 pp
2012 72.3% CN¥4.71 Billion CN¥6.51 Billion CN¥1.80 Billion ▲ +0.9 pp
2011 71.5% CN¥4.34 Billion CN¥6.08 Billion CN¥1.73 Billion ▼ -3.9 pp
2010 75.4% CN¥3.93 Billion CN¥5.21 Billion CN¥1.28 Billion ▲ +0.5 pp
2009 74.9% CN¥3.53 Billion CN¥4.72 Billion CN¥1.18 Billion ▲ +1.1 pp
2008 73.8% CN¥3.15 Billion CN¥4.27 Billion CN¥1.12 Billion ▲ +9.4 pp
2007 64.4% CN¥2.36 Billion CN¥3.67 Billion CN¥1.31 Billion ▲ +3.2 pp
2006 61.2% CN¥2.00 Billion CN¥3.26 Billion CN¥1.26 Billion ▲ +10.4 pp
2005 50.9% CN¥1.94 Billion CN¥3.81 Billion CN¥1.87 Billion ▲ +7.9 pp
2004 42.9% CN¥1.73 Billion CN¥4.03 Billion CN¥2.30 Billion ▲ +2.6 pp
2003 40.3% CN¥1.72 Billion CN¥4.26 Billion CN¥2.54 Billion ▼ -4.1 pp
2002 44.4% CN¥1.60 Billion CN¥3.62 Billion CN¥2.01 Billion ▼ -9.9 pp
2001 54.3% CN¥1.49 Billion CN¥2.75 Billion CN¥1.26 Billion ▼ -3.4 pp
2000 57.6% CN¥855.27 Million CN¥1.48 Billion CN¥628.89 Million ▼ -2.4 pp
1999 60.0% CN¥711.23 Million CN¥1.18 Billion CN¥473.60 Million ▼ -13.0 pp
1998 73.1% CN¥541.45 Million CN¥741.02 Million CN¥199.57 Million ▼ -9.2 pp
1997 82.3% CN¥472.91 Million CN¥574.69 Million CN¥101.78 Million ▲ +13.7 pp
1996 68.6% CN¥105.81 Million CN¥154.30 Million CN¥48.49 Million ▼ -9.4 pp
1995 78.0% CN¥103.12 Million CN¥132.29 Million CN¥29.17 Million ▲ +5.7 pp
1994 72.3% CN¥94.91 Million CN¥131.33 Million CN¥36.42 Million
pp = percentage points